article thumbnail

The democratisation of cell and gene therapy

Drug Discovery World

He says: “What we are seeing from a molecular biology perspective is that the genetic material that we want to pack into viral vectors is becoming increasingly complicated. We are now looking at larger plasmid DNA sequences to carry more genetic material, and so we can get a more delicate endpoint with a much larger plasmid DNA sequence.

article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. Continuing advancements within this field deliver new hope to doctors and patients, transforming disease outcomes for previously incurable indications.

Drugs 295
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What to expect from SLAS Europe 2023

Drug Discovery World

BMG LABTECH develops and manufactures innovative, high- quality, and reliable microplate reader instrumentation, while Microtechnix (MTX) is a company providing innovative solutions for biological laboratory assays. Meanwhile, Curiox Biosystems is enabling accurate biological analysis through automation. It will be led by Björn C.

Doctors 52
article thumbnail

Moderna and NIH Embroiled in Ownership Dispute Over COVID-19 Vaccine Patent

XTalks

The COVID-19 vaccine patent is for the specific genetic sequence of the spike protein used in the Spikevax vaccine. NIH says three of its scientists — Dr. John Mascola, Dr. Barney Graham and Dr. Kizzmekia Corbett — assisted in the design of the spike genetic sequence and should, therefore, be included on the patent application.

article thumbnail

AZ, J&J tweaking COVID shots to reduce clotting risks; report

pharmaphorum

At the same time, the UK’s National Institute for Health and Care excellence (NICE) is developing guidance to help doctors manage the cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) and low blood platelet counts that have been seen with the COVID-19 vaccines.

article thumbnail

How Will Ultima Genomics and Genome Insight Make WGS Affordable?

XTalks

Genome sequencing requires a powerful sequencer to decode the genetic makeup and an equally powerful analysis platform to make sense of the data generated. WGS can also help identify the specific genetic alterations that underlie drug resistance in cancer cells. Is Whole Genome Sequencing Covered by Insurance?

Genome 97
article thumbnail

Gene editing: beyond the hype

pharmaphorum

This has, of course, garnered immense excitement – Doctors Emmanuelle Charpentier and Jennifer Doudna were named winners of the Nobel Prize for chemistry in recognition of their discovery of CRISPR/Cas9 gene editing technology. It has also built its own manufacturing site and launched partnerships with six big pharma companies.